ADVICE RECEIVED FROM AGVA
RE: AVAILABILITY OF ETHYLOESTRENOL
Greyhounds Australasia (GA) has received advice from
the Australian Greyhound Veterinary Association (AGVA)
that sufficient levels of Ethyloestrenol will still be
available in Australian veterinary products despite the
phase out of the branded tablet “Nandoral”
after the product’s current expiry date of 30 September
2008.
Advice received confirms that pharmaceutical manufacturer,
Nature Vet has produced and will supply directly to veterinarians
a new Ethyloestrenol tablet called “Oestrotain”.
It’s important to note that GA doesn’t endorse
specific pharmaceutical products but seeks only to provide
information to the industry after consultation with the
AGVA.
If participants have any concerns in relation to this
matter and particularly if they are contemplating the
use of Ethyloestrenol, it is highly recommended that they
consult their veterinarian.
The allowance of the prescribed use by oral administration
of Ethyloestrenol follows direction from Greyhounds Australasia
and is now adopted as a rule by all greyhound racing controlling
bodies in Australia.
This rule is designed to offer trainers a veterinary
alternative to prevent bitches coming into season and
making them unable to race, while not unduly enhancing
performance or significantly impacting on the animal’s
welfare.
CRAIG TABERNER
CHIEF EXECUTIVE OFFICER
Ph: (03) 9548 3500
Please note:
GA reminds participants that Nandoral tablets, Oestrotain
tablets and Nitrotain paste are brands of veterinary products
that contain Ethyloestrenol. However neither the GA Board
nor the various State and Territory controlling bodies
have the legal right to endorse the prescription of these
or other Ethyloestrenol products - that is a legal right
of veterinarians.
|
